Quick Heal Technologies Ltd Stock Price Today (NSE: QUICKHEAL)
Fundamental Score
Quick Heal Technologies Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Quick Heal Technologies Ltd share price today is ₹187.15, up +0.00% on NSE/BSE as of 17 February 2026. Quick Heal Technologies Ltd (QUICKHEAL) is a Small-cap company in the Software Products sector with a market capitalisation of ₹1.67K (Cr). The 52-week high for QUICKHEAL share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of 0.63% and a debt-to-equity ratio of 0.00.
Quick Heal Technologies Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Quick Heal Technologies Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Quick Heal Technologies Share Price Analysis: A ROCE Efficiency Perspective
The software products industry is undergoing a significant shift, with cybersecurity solutions needing constant innovation to stay ahead of evolving threats. This makes Return on Capital Employed (ROCE) a crucial metric for evaluating a company's effectiveness in deploying capital to generate profits. This analysis examines the current financial standing of Quick Heal Technologies, with specific attention on its ROCE. Currently, the Quick Heal Technologies share price stands at ₹180.02999877929688. The company's reported PE ratio is unavailable, and its ROCE sits at a concerning -0.24%.
ROCE is a key indicator of how efficiently a company uses its capital to generate profits. A negative ROCE, such as Quick Heal Technologies’ -0.24%, suggests that the company is currently not generating sufficient returns relative to the capital it has invested. This can stem from various factors, including declining revenues, increased operating expenses, or inefficient asset utilization. It is important to investigate the drivers of this negative return, such as evaluating project selection.
A low or negative ROCE can significantly impact a company's competitive advantage or "moat." A strong moat is built on sustained profitability and efficient capital allocation. When a company struggles to generate returns on its investments, it becomes more vulnerable to competition. Its capacity to invest in innovation, product development, and market expansion is limited. Contrast this with a hypothetical scenario where
Aion Tech Solutions Ltd possesses a higher ROCE, possibly signifying better management quality and efficient resource allocation, giving them a potential edge in the marketplace.Considering Quick Heal's sector peers, such as Infronics Systems Ltd and Silicon Valley companies, understanding their respective ROCE and PE ratios provides a comparative benchmark. A detailed analysis of the entire peer group is essential for contextualizing Quick Heal's performance. Further investigation is needed to understand the underlying causes of the negative ROCE and to assess management's plans for improvement and whether they are likely to produce an adequate ROCE in the intermediate term.
Disclaimer: This financial analysis of Quick Heal Technologies Ltd share price focuses on observational data and does not constitute investment advice. This analysis is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, and is intended for informational purposes only. Investors should conduct their own due diligence before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Quick Heal Technologies Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of QUICKHEAL across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Operating Margins (17.16%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (90.60%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹175.68 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (71.63%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (0.63%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-0.24%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Limited Growth History (-0.47% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-46.12% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-47.96% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (-23.35x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Limited Institutional Interest (FII+DII: 2.83%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Quick Heal Technologies Ltd Financial Statements
Comprehensive financial data for Quick Heal Technologies Ltd including income statement, balance sheet and cash flow
About QUICKHEAL (Quick Heal Technologies Ltd)
Quick Heal Technologies Ltd (QUICKHEAL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Software Products sector with a current market capitalisation of ₹1.67K (Cr). Quick Heal Technologies Ltd has delivered a Return on Equity (ROE) of 0.63% and a ROCE of -0.24%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking QUICKHEAL share price can monitor key metrics including P/E ratio, promoter holding of 71.63%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
QUICKHEAL Share Price: Frequently Asked Questions
What is the current share price of Quick Heal Technologies Ltd (QUICKHEAL)?
As of 17 Feb 2026, 10:19 am IST, Quick Heal Technologies Ltd share price is ₹187.15. The QUICKHEAL stock has a market capitalisation of ₹1.67K (Cr) on NSE/BSE.
Is QUICKHEAL share price Overvalued or Undervalued?
QUICKHEAL share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 36.75x. Based on this relative valuation, the Quick Heal Technologies Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of QUICKHEAL share price?
The 52-week high of QUICKHEAL share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Quick Heal Technologies Ltd share price?
Key factors influencing QUICKHEAL share price include quarterly earnings growth (Sales Growth: 13.65%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Quick Heal Technologies Ltd a good stock for long-term investment?
Quick Heal Technologies Ltd shows a 5-year Profit Growth of -47.96% and an ROE of 0.63%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in QUICKHEAL shares.
How does Quick Heal Technologies Ltd compare with its industry peers?
Quick Heal Technologies Ltd competes with major peers in the Software Products. Investors should compare QUICKHEAL share price P/E of 0.00x and ROE of 0.63% against the industry averages to determine competitive standing.
What is the P/E ratio of QUICKHEAL and what does it mean?
QUICKHEAL share price has a P/E ratio of N/Ax compared to the industry average of 36.75x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is QUICKHEAL performing according to Bull Run's analysis?
QUICKHEAL has a Bull Run fundamental score of 32/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does QUICKHEAL belong to?
QUICKHEAL operates in the Software Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Quick Heal Technologies Ltd share price.
What is Return on Equity (ROE) and why is it important for QUICKHEAL?
QUICKHEAL has an ROE of 0.63%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Quick Heal Technologies Ltd generates profits from shareholders capital.
How is QUICKHEAL debt-to-equity ratio and what does it indicate?
QUICKHEAL has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is QUICKHEAL dividend yield and is it a good dividend stock?
QUICKHEAL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Quick Heal Technologies Ltd shares.
How has QUICKHEAL share price grown over the past 5 years?
QUICKHEAL has achieved 5-year growth rates of: Sales Growth -0.47%, Profit Growth -47.96%, and EPS Growth -46.12%.
What is the promoter holding in QUICKHEAL and why does it matter?
Promoters hold 71.63% of QUICKHEAL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Quick Heal Technologies Ltd.
What is QUICKHEAL market capitalisation category?
QUICKHEAL has a market capitalisation of ₹1668 crores, placing it in the Small-cap category.
How volatile is QUICKHEAL stock?
QUICKHEAL has a beta of N/A. A beta > 1 suggests the Quick Heal Technologies Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is QUICKHEAL operating profit margin trend?
QUICKHEAL has a 5-year average Operating Profit Margin (OPM) of 17.16%, indicating the company's operational efficiency.
How is QUICKHEAL quarterly performance?
Recent quarterly performance shows Quick Heal Technologies Ltd YoY Sales Growth of 13.65% and YoY Profit Growth of 90.60%.
What is the institutional holding pattern in QUICKHEAL?
QUICKHEAL has FII holding of 0.50% and DII holding of 2.33%. Significant institutional holding often suggests professional confidence in the Quick Heal Technologies Ltd stock.